• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bioharvest Sciences Inc (CSE: BHSC )

    7.300 +0.100 (+1.39%)
    Official Closing Price Updated: 3:34 PM EDT, Sep 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,776
    Open 7.240
    Bid (Size) 7.250 (100)
    Ask (Size) 7.750 (200)
    Prev. Close 7.200
    Today's Range 7.240 - 7.600
    52wk Range 0.1600 - 9.200
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioHarvest Sciences to Present at H.C. Wainwright 26th Annual Global Investment Conference
    Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - September 4, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or... 
    Via Newsfile
    BioHarvest Sciences Reports Record Second Quarter 2024 Financial Results
    Q2 2024 Revenue Increased 119% Year-over-Year to Over $6.0 Million, Exceeding Management Guidance Management Expects Third Quarter 2024 Revenues of... 
    Via Newsfile

    Performance

    YTD
    +3376.19%
    +3376.19%
    1 Month
    -7.59%
    -7.59%
    3 Month
    -16.57%
    -16.57%
    6 Month
    +3218.18%
    +3218.18%
    1 Year
    +3955.56%
    +3955.56%

    More News

    Read More
    BioHarvest Sciences Surpasses USD $1.0 Million in Cumulative Direct Sales of Coffee with VINIA Inside
    Via Newsfile
    BioHarvest Sciences to Host Second Quarter 2024 Corporate Update Call on August 29, 2024, at 2:30 p.m. Eastern Time
    Via Newsfile
    BioHarvest Sciences Announces Closing of USD $4,329,982 in First Tranche of Private Placement and Conversion of Debt Notes
    Via Newsfile
    BioHarvest Sciences to Present at Noble Capital Markets Virtual Equity Conference on June 27, 2024
    Via Newsfile
    BioHarvest Sciences Announces a Private Placement of up to USD $5 Million and Conversion of Debt Notes
    Via Newsfile
    BioHarvest Sciences to Present at Sidoti Small-Cap Virtual Investor Conference on June 13, 2024
    Via Newsfile
    BioHarvest Sciences Announces Record $2 Million Monthly Sales
    Via Newsfile
    BioHarvest Sciences Reports First Quarter 2024 Financial Results
    Via Newsfile
    BioHarvest Sciences to Host Corporate Update Call May 2 at 2:30 P.M. Eastern Time
    Via Newsfile
    BioHarvest Sciences Reports Fourth Quarter and Full Year 2023 Financial Results
    Via Newsfile
    BioHarvest Sciences Announces New Campus for Botanical Synthesis CDMO and Expansion of Manufacturing Capacity
    Via Newsfile
    BioHarvest Sciences Appoints Anna Tenstam as VP of Business Development, Cosmeceuticals and Injectables
    Via Newsfile
    Benzinga's 2024 Virtual Healthcare: What's Next In Health?
    Via Benzinga
    BioHarvest Sciences to Participate in Benzinga Virtual Healthcare Summit 2024 on March 20, 2024
    Via Newsfile
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    BioHarvest Sciences Announces New Strategic Hires for CDMO Services Business Unit
    Via Newsfile
    RETRANSMISSION: iAccess Alpha's Buyside Best Ideas Spring Virtual Conference March 12th and 13th, 2024
    Via ACCESSWIRE
    BioHarvest Sciences to Participate in iAccess Alpha Buyside Best Ideas Conference on March 12-13, 2024
    Via Newsfile
    BioHarvest Sciences to Host Corporate Update Discussing Launch of CDMO Business Unit on March 13 at 2:30 p.m. Eastern Time
    Via Newsfile
    BioHarvest Sciences Signs First Contracts with Two Industrial Customers to Develop Complex Molecules via Its Newly Launched Botanical Synthesis CDMO Business Unit
    Via Newsfile
    BioHarvest Sciences Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
    Via Newsfile
    BioHarvest Sciences to Present at the 2024 BIO CEO & Investor Conference
    Via Newsfile
    BioHarvest Issues 2023 Year End Shareholder Letter and Provides Corporate Update
    Via Newsfile
    Life Science Investor Forum: Presentations Now Available for Online Viewing
    From Virtual Investor Conferences
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.